Skip to main content
. 2024 Jan 29;25(3):1632. doi: 10.3390/ijms25031632

Table 1.

Gender and cancer stage and grade distribution in the study cohort.

Cancer Group, n (%) Control Group, n (%) Total, n (%) p-Value
Gender Females 31 (44.0%) 40 (56.0%) 71 (100.0%) 0.836
Males 47 (58.0%) 34 (42.0%) 81 (100.0%)
Total included 78 (51.0%) 74 (49.0%) 152 (100.0%) -
Cancer stage I 16 (21.0%) - - -
II 37 (47.0%) - -
III 19 (24.0%) - -
IV 6 (8.0%) - -
Cancer differentiation grade 1 23 (29.0%) - - -
2 43 (55.0%) - -
3 12 (15.0%) - -

n—number of study participants.